- Case-Based Modules
- Initial Evaluation
- Dermatologic Manifestations
- Oral Manifestations
- OIs: Prophylaxis
- OIs: Treatment
- Antiretroviral Rx
- Antiretroviral Rx: Resistance
- Antiretroviral Rx: Adverse Effects
- Drug-Drug Interactions
- Postexposure Prophylaxis
- Perinatal Transmission
- Special Populations
- Prevention for Positives
- Challenging Unknowns
- Resource-Limited Settings
- Interactive Tutorials
- Routine HIV Screening
- Oraquick Advance Rapid HIV Test
- HIV Integration
- This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.
Antiretroviral Rx: Adverse Effects
Question | Discussion | References | CME Credit
Case 7: Efavirenz-Associated Central Nervous System Adverse Effects
You answered:
 |
After initiating therapy with an efavirenz-containing regimen, the development of early central nervous system adverse effects, such as dizziness, mild cognitive difficulty, fatigue, and sleep disturbances, usually improve within 4 weeks. |
|---|
This answer is correct. Available data suggest that, in most patients, the early central nervous system adverse effects markedly improve or completely resolve within 4 weeks after starting efavirenz.
Copyright © 2004-2013 University of Washington